CN Stock MarketDetailed Quotes

Allmed Medical Products (002950)

Watchlist
  • 13.16
  • -0.34-2.52%
Market Closed Apr 17 15:00 CST
8.33BMarket Cap18.43P/E (TTM)

Allmed Medical Products (002950) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
5.98%2.6B
5.99%1.68B
1.64%758.66M
20.66%3.33B
21.39%2.45B
10.86%1.58B
-8.38%746.41M
-34.53%2.76B
-34.20%2.02B
-33.16%1.43B
Operating revenue
5.98%2.6B
5.99%1.68B
1.64%758.66M
20.66%3.33B
21.39%2.45B
10.86%1.58B
-8.38%746.41M
-34.53%2.76B
-34.20%2.02B
-33.16%1.43B
Other operating revenue
----
11.41%20.28M
----
-32.96%33.12M
----
221.85%18.2M
----
213.07%49.4M
----
-26.56%5.66M
Total operating cost
2.32%2.19B
4.41%1.42B
2.39%659.49M
14.32%2.87B
18.35%2.14B
10.77%1.36B
-5.03%644.08M
-29.33%2.51B
-32.45%1.81B
-31.04%1.23B
Operating cost
3.09%1.82B
4.77%1.18B
-0.83%527.15M
19.16%2.37B
24.47%1.76B
14.43%1.13B
-1.93%531.56M
-28.84%1.99B
-30.09%1.42B
-29.05%983.88M
Operating tax surcharges
52.38%22.92M
43.27%13.87M
-2.98%4.47M
-3.92%18.5M
14.07%15.04M
3.73%9.68M
-12.64%4.61M
-27.28%19.25M
-37.57%13.19M
-39.91%9.33M
Operating expense
12.85%78.7M
17.59%51.16M
28.00%24M
46.00%95.91M
54.63%69.74M
38.60%43.51M
-17.51%18.75M
-21.61%65.69M
-41.65%45.1M
-39.80%31.39M
Administration expense
-10.05%192.53M
-5.15%128.16M
15.11%74.86M
-12.90%281.93M
-15.47%214.04M
-19.47%135.12M
-28.39%65.03M
-11.55%323.67M
-16.83%253.19M
-19.29%167.8M
Financial expense
-103.72%-679.55K
-191.42%-8.87M
-114.23%-806.77K
-94.16%2.33M
-2.12%18.28M
3,001.39%9.7M
228.16%5.67M
-77.74%39.9M
-90.66%18.67M
-100.37%-334.24K
-Interest expense (Financial expense)
-52.48%10.04M
-46.73%7.88M
-40.09%4.86M
-19.90%25.53M
-14.07%21.13M
-11.00%14.79M
-23.34%8.11M
-10.16%31.87M
-26.36%24.59M
20.12%16.62M
-Interest Income (Financial expense)
-114.54%-10.46M
-359.09%-7.5M
-178.21%-2.08M
-283.32%-7.16M
-285.90%-4.87M
-122.07%-1.63M
-64.81%-749.31K
39.53%-1.87M
41.73%-1.26M
52.37%-735.8K
Research and development
32.39%76.6M
51.59%58.83M
61.54%29.82M
37.49%106.37M
-3.67%57.85M
2.03%38.81M
-15.41%18.46M
-28.19%77.37M
31.61%60.06M
21.31%38.04M
Credit Impairment Loss
271.36%3.14M
101.64%34.84K
121.76%1.58M
-90.02%-3.05M
-159.37%-1.83M
-202.04%-2.12M
152.88%710.62K
7.04%-1.61M
1,265.25%3.08M
244.59%2.08M
Asset Impairment Loss
-451.21%-14.99M
-4,167.33%-19.56M
-324.00%-2.9M
69.54%-32.81M
89.69%-2.72M
96.46%-458.34K
89.22%-684.77K
-628.77%-107.73M
-276.82%-26.37M
-199.69%-12.93M
Other net revenue
2.13%20.95M
-111.67%-2.04M
-0.62%13.48M
108.24%6.08M
251.07%20.52M
3,626.76%17.46M
4.12%13.56M
42.57%-73.7M
89.05%-13.58M
-90.76%468.48K
Fair value change income
161.58%4.23M
167.17%4.51M
193.07%4.61M
-141.53%-21.91M
-112.33%-6.86M
-113.00%-6.71M
-108.11%-4.96M
191.63%52.75M
137.93%55.67M
234.20%51.65M
Invest income
-246.89%-4.89M
-199.02%-5.47M
-118.87%-974.59K
97.70%-1.37M
105.38%3.33M
110.82%5.53M
110.91%5.16M
41.89%-59.63M
-577.40%-61.84M
-337.67%-51.07M
-Including: Investment income associates
-113.70%-12.9M
-198.75%-7.3M
-157.58%-1.56M
-117.02%-1.68M
-673.04%-6.04M
-135.61%-2.44M
-32.02%2.7M
-60.09%9.87M
-88.01%1.05M
-18.38%6.86M
Asset deal income
102.98%16.91K
102.98%16.91K
635.18%46.47K
39,592.65%28.79M
-1,893.40%-567.52K
-1,893.40%-567.52K
-124.07%-8.68K
-102.08%-72.9K
-99.38%31.64K
-99.39%31.64K
Other revenue
14.69%33.45M
-15.43%18.43M
-16.62%11.12M
-14.47%36.43M
84.15%29.17M
103.44%21.79M
152.12%13.34M
-5.05%42.59M
-52.80%15.84M
-52.72%10.71M
Operating profit
29.35%428.6M
6.40%251.59M
-2.80%112.65M
171.19%458.46M
68.13%331.35M
19.98%236.47M
-22.46%115.89M
-67.80%169.06M
-26.24%197.08M
-44.57%197.08M
Add:Non operating Income
-59.68%646.64K
-40.44%623.95K
-65.37%18.14K
-23.85%2.05M
-3.31%1.6M
5.49%1.05M
65.60%52.37K
81.26%2.69M
157.06%1.66M
62.38%993.08K
Less:Non operating expense
-46.25%1.32M
-50.31%1.16M
-18.66%1.04M
126.08%6.12M
90.57%2.45M
268.75%2.33M
544.70%1.28M
-93.50%2.71M
-93.07%1.29M
-83.83%632.77K
Total profit
29.48%427.93M
6.75%251.06M
-2.65%111.62M
168.80%454.39M
67.39%330.51M
19.11%235.18M
-23.19%114.66M
-65.14%169.04M
-20.79%197.45M
-43.95%197.44M
Less:Income tax cost
12.68%73.04M
-0.46%47.68M
21.59%24.97M
32.04%85.59M
23.81%64.82M
12.62%47.9M
-8.26%20.54M
-19.23%64.83M
-0.31%52.36M
-31.69%42.53M
Net profit
33.57%354.89M
8.59%203.38M
-7.94%86.65M
253.87%368.8M
83.11%265.68M
20.90%187.28M
-25.83%94.13M
-74.24%104.22M
-26.25%145.1M
-46.58%154.91M
Net profit from continuing operation
33.57%354.89M
8.59%203.38M
-7.94%86.65M
253.87%368.8M
83.11%265.68M
20.90%187.28M
-25.83%94.13M
-74.24%104.22M
-26.25%145.1M
-46.58%154.91M
Less:Minority Profit
1,073.04%6.08M
1,138.76%3.54M
-39.37%150.13K
101.90%117.53K
109.77%518.47K
113.42%285.9K
125.24%247.61K
-187.70%-6.18M
-4,176.54%-5.31M
-2,278.54%-2.13M
Net profit of parent company owners
31.54%348.8M
6.87%199.84M
-7.86%86.5M
233.95%368.68M
76.30%265.17M
19.08%187M
-26.59%93.88M
-72.86%110.4M
-23.60%150.41M
-45.87%157.04M
Earning per share
Basic earning per share
30.38%0.5519
6.33%0.316
-7.83%0.1366
247.06%0.59
78.23%0.4233
19.84%0.2972
-26.60%0.1482
-73.54%0.17
-23.61%0.2375
-45.86%0.248
Diluted earning per share
30.38%0.5519
6.33%0.316
-7.83%0.1366
247.06%0.59
78.23%0.4233
19.84%0.2972
-26.60%0.1482
-73.54%0.17
-23.61%0.2375
-45.86%0.248
Other composite income
128.89%651.98K
117.56%938.09K
121.16%651.01K
-238.89%-19.14M
-1.91%-2.26M
-142.99%-5.34M
86.79%-3.08M
-82.32%13.78M
-102.39%-2.21M
-105.39%-2.2M
Other composite income of parent company owners
128.89%651.98K
117.56%938.09K
121.16%651.01K
-238.89%-19.14M
-1.91%-2.26M
-142.99%-5.34M
86.79%-3.08M
-82.32%13.78M
-102.39%-2.21M
-105.39%-2.2M
Total composite income
34.97%355.54M
12.30%204.32M
-4.11%87.3M
196.33%349.66M
84.37%263.43M
19.14%181.94M
-12.12%91.05M
-75.55%118M
-50.65%142.88M
-53.84%152.71M
Total composite income of parent company owners
32.92%349.46M
10.52%200.77M
-4.02%87.15M
181.48%349.54M
77.41%262.91M
17.32%181.66M
-13.18%90.8M
-74.38%124.18M
-48.84%148.19M
-53.21%154.84M
Total composite income of minority owners
1,073.04%6.08M
1,138.76%3.54M
-39.37%150.13K
101.90%117.53K
109.77%518.47K
113.42%285.9K
125.24%247.61K
-187.70%-6.18M
-4,176.54%-5.31M
-2,278.54%-2.13M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 5.98%2.6B5.99%1.68B1.64%758.66M20.66%3.33B21.39%2.45B10.86%1.58B-8.38%746.41M-34.53%2.76B-34.20%2.02B-33.16%1.43B
Operating revenue 5.98%2.6B5.99%1.68B1.64%758.66M20.66%3.33B21.39%2.45B10.86%1.58B-8.38%746.41M-34.53%2.76B-34.20%2.02B-33.16%1.43B
Other operating revenue ----11.41%20.28M-----32.96%33.12M----221.85%18.2M----213.07%49.4M-----26.56%5.66M
Total operating cost 2.32%2.19B4.41%1.42B2.39%659.49M14.32%2.87B18.35%2.14B10.77%1.36B-5.03%644.08M-29.33%2.51B-32.45%1.81B-31.04%1.23B
Operating cost 3.09%1.82B4.77%1.18B-0.83%527.15M19.16%2.37B24.47%1.76B14.43%1.13B-1.93%531.56M-28.84%1.99B-30.09%1.42B-29.05%983.88M
Operating tax surcharges 52.38%22.92M43.27%13.87M-2.98%4.47M-3.92%18.5M14.07%15.04M3.73%9.68M-12.64%4.61M-27.28%19.25M-37.57%13.19M-39.91%9.33M
Operating expense 12.85%78.7M17.59%51.16M28.00%24M46.00%95.91M54.63%69.74M38.60%43.51M-17.51%18.75M-21.61%65.69M-41.65%45.1M-39.80%31.39M
Administration expense -10.05%192.53M-5.15%128.16M15.11%74.86M-12.90%281.93M-15.47%214.04M-19.47%135.12M-28.39%65.03M-11.55%323.67M-16.83%253.19M-19.29%167.8M
Financial expense -103.72%-679.55K-191.42%-8.87M-114.23%-806.77K-94.16%2.33M-2.12%18.28M3,001.39%9.7M228.16%5.67M-77.74%39.9M-90.66%18.67M-100.37%-334.24K
-Interest expense (Financial expense) -52.48%10.04M-46.73%7.88M-40.09%4.86M-19.90%25.53M-14.07%21.13M-11.00%14.79M-23.34%8.11M-10.16%31.87M-26.36%24.59M20.12%16.62M
-Interest Income (Financial expense) -114.54%-10.46M-359.09%-7.5M-178.21%-2.08M-283.32%-7.16M-285.90%-4.87M-122.07%-1.63M-64.81%-749.31K39.53%-1.87M41.73%-1.26M52.37%-735.8K
Research and development 32.39%76.6M51.59%58.83M61.54%29.82M37.49%106.37M-3.67%57.85M2.03%38.81M-15.41%18.46M-28.19%77.37M31.61%60.06M21.31%38.04M
Credit Impairment Loss 271.36%3.14M101.64%34.84K121.76%1.58M-90.02%-3.05M-159.37%-1.83M-202.04%-2.12M152.88%710.62K7.04%-1.61M1,265.25%3.08M244.59%2.08M
Asset Impairment Loss -451.21%-14.99M-4,167.33%-19.56M-324.00%-2.9M69.54%-32.81M89.69%-2.72M96.46%-458.34K89.22%-684.77K-628.77%-107.73M-276.82%-26.37M-199.69%-12.93M
Other net revenue 2.13%20.95M-111.67%-2.04M-0.62%13.48M108.24%6.08M251.07%20.52M3,626.76%17.46M4.12%13.56M42.57%-73.7M89.05%-13.58M-90.76%468.48K
Fair value change income 161.58%4.23M167.17%4.51M193.07%4.61M-141.53%-21.91M-112.33%-6.86M-113.00%-6.71M-108.11%-4.96M191.63%52.75M137.93%55.67M234.20%51.65M
Invest income -246.89%-4.89M-199.02%-5.47M-118.87%-974.59K97.70%-1.37M105.38%3.33M110.82%5.53M110.91%5.16M41.89%-59.63M-577.40%-61.84M-337.67%-51.07M
-Including: Investment income associates -113.70%-12.9M-198.75%-7.3M-157.58%-1.56M-117.02%-1.68M-673.04%-6.04M-135.61%-2.44M-32.02%2.7M-60.09%9.87M-88.01%1.05M-18.38%6.86M
Asset deal income 102.98%16.91K102.98%16.91K635.18%46.47K39,592.65%28.79M-1,893.40%-567.52K-1,893.40%-567.52K-124.07%-8.68K-102.08%-72.9K-99.38%31.64K-99.39%31.64K
Other revenue 14.69%33.45M-15.43%18.43M-16.62%11.12M-14.47%36.43M84.15%29.17M103.44%21.79M152.12%13.34M-5.05%42.59M-52.80%15.84M-52.72%10.71M
Operating profit 29.35%428.6M6.40%251.59M-2.80%112.65M171.19%458.46M68.13%331.35M19.98%236.47M-22.46%115.89M-67.80%169.06M-26.24%197.08M-44.57%197.08M
Add:Non operating Income -59.68%646.64K-40.44%623.95K-65.37%18.14K-23.85%2.05M-3.31%1.6M5.49%1.05M65.60%52.37K81.26%2.69M157.06%1.66M62.38%993.08K
Less:Non operating expense -46.25%1.32M-50.31%1.16M-18.66%1.04M126.08%6.12M90.57%2.45M268.75%2.33M544.70%1.28M-93.50%2.71M-93.07%1.29M-83.83%632.77K
Total profit 29.48%427.93M6.75%251.06M-2.65%111.62M168.80%454.39M67.39%330.51M19.11%235.18M-23.19%114.66M-65.14%169.04M-20.79%197.45M-43.95%197.44M
Less:Income tax cost 12.68%73.04M-0.46%47.68M21.59%24.97M32.04%85.59M23.81%64.82M12.62%47.9M-8.26%20.54M-19.23%64.83M-0.31%52.36M-31.69%42.53M
Net profit 33.57%354.89M8.59%203.38M-7.94%86.65M253.87%368.8M83.11%265.68M20.90%187.28M-25.83%94.13M-74.24%104.22M-26.25%145.1M-46.58%154.91M
Net profit from continuing operation 33.57%354.89M8.59%203.38M-7.94%86.65M253.87%368.8M83.11%265.68M20.90%187.28M-25.83%94.13M-74.24%104.22M-26.25%145.1M-46.58%154.91M
Less:Minority Profit 1,073.04%6.08M1,138.76%3.54M-39.37%150.13K101.90%117.53K109.77%518.47K113.42%285.9K125.24%247.61K-187.70%-6.18M-4,176.54%-5.31M-2,278.54%-2.13M
Net profit of parent company owners 31.54%348.8M6.87%199.84M-7.86%86.5M233.95%368.68M76.30%265.17M19.08%187M-26.59%93.88M-72.86%110.4M-23.60%150.41M-45.87%157.04M
Earning per share
Basic earning per share 30.38%0.55196.33%0.316-7.83%0.1366247.06%0.5978.23%0.423319.84%0.2972-26.60%0.1482-73.54%0.17-23.61%0.2375-45.86%0.248
Diluted earning per share 30.38%0.55196.33%0.316-7.83%0.1366247.06%0.5978.23%0.423319.84%0.2972-26.60%0.1482-73.54%0.17-23.61%0.2375-45.86%0.248
Other composite income 128.89%651.98K117.56%938.09K121.16%651.01K-238.89%-19.14M-1.91%-2.26M-142.99%-5.34M86.79%-3.08M-82.32%13.78M-102.39%-2.21M-105.39%-2.2M
Other composite income of parent company owners 128.89%651.98K117.56%938.09K121.16%651.01K-238.89%-19.14M-1.91%-2.26M-142.99%-5.34M86.79%-3.08M-82.32%13.78M-102.39%-2.21M-105.39%-2.2M
Total composite income 34.97%355.54M12.30%204.32M-4.11%87.3M196.33%349.66M84.37%263.43M19.14%181.94M-12.12%91.05M-75.55%118M-50.65%142.88M-53.84%152.71M
Total composite income of parent company owners 32.92%349.46M10.52%200.77M-4.02%87.15M181.48%349.54M77.41%262.91M17.32%181.66M-13.18%90.8M-74.38%124.18M-48.84%148.19M-53.21%154.84M
Total composite income of minority owners 1,073.04%6.08M1,138.76%3.54M-39.37%150.13K101.90%117.53K109.77%518.47K113.42%285.9K125.24%247.61K-187.70%-6.18M-4,176.54%-5.31M-2,278.54%-2.13M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More